HEALTHCARE

09 Sep 2016

Patient Safety Movement Foundation & Global Sepsis Alliance Join Forces to Reduce Preventable Deaths from Sepsis

The Patient Safety Movement Foundation is happy to announce its sponsorship and participation in the 1st World Sepsis Congress on September 8-9, 2016, convened by the Global Sepsis Alliance. Featured speakers include German Minister of State, Dr. Helge Braun, Joe Kiani, Founder of the Patient"...

Continue Reading

09 Sep 2016

Orphan Drug Designation Granted to Nintedanib for Treatment of Systemic Sclerosis, including Associated Interstitial Lung Disease

Boehringer Ingelheim today announced that the European Commission (EC) and U.S. Food and Drug Administration (FDA) have granted Orphan Drug Designation to nintedanib for the treatment of systemic sclerosis (SSc, also known as scleroderma), including the associated interstitial lung disease"...

Continue Reading

08 Sep 2016

Acelity Launches PREVENA PLUS™ Incision Management System with Customizable Dressing for a Range of Complex Procedures

Acelity, a global wound care and regenerative medicine company, today announced the expansion of its PREVENA™ Therapy portfolio with the global launch of the PREVENA PLUS™ Incision Management System. The PREVENA PLUS™ System offers the proven effectiveness of closed incision negative"...

Continue Reading

08 Sep 2016

New analysis showed dose adjustment of Giotrif® (afatinib) improved tolerability without an apparent impact on efficacy in patients with EGFR mutation-positive non-small cell lung cancer

  • A new analysis from two Phase III trials published in Annals of Oncology showed that adjusting afatinib dosing based on tolerability reduced the incidence and severity of treatment-related adverse events with no apparent impact on efficacy


07 Sep 2016

GORE® VIABAHN® Endoprosthesis Marks 20 Years of Proven Performance

W. L. Gore & Associates, Inc. (Gore) is celebrating the 20th anniversary of the introduction of the GORE® VIABAHN® Endoprosthesis, the market-leading stent-graft for the treatment of complex peripheral vascular disease. The device has been engineered to effectively cover and seal"......

Continue Reading

07 Sep 2016

New long-term data demonstrates continued safety and beneficial effect of OFEV® (nintedanib) for patients with IPF

  • Interim data suggest long-term benefit with consistent yearly changes in forced vital capacity up to 3 years in patients treated with OFEV® in INPULSIS® and INPULSIS®-ON
  • Long-term treatment up to 51 months had a manageable safety and tolerability profile, with no new safety signals identified
  • Additional INPULSIS® analyses...

    Continue Reading

07 Sep 2016

Acelity Announces Exchange Offer and Consent Solicitation with Respect to Senior Notes Due 2019

Acelity L.P. Inc. (“Acelity”), a global advanced wound care and regenerative medicine company, announced today that its wholly-owned subsidiaries, Kinetic Concepts, Inc.

(“KCI”) and KCI"...

Continue Reading

07 Sep 2016

Takeda Initiates Global Phase 3 Clinical Trial (TIDES) of Dengue Vaccine Candidate (TAK-003)

Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) today announced that it has vaccinated the first subject in the Tetravalent Immunization against Dengue Efficacy Study (TIDES), a Phase 3 double-blind, randomized and placebo-controlled trial of its live-attenuated tetravalent dengue vaccine"......

Continue Reading

06 Sep 2016

Tiotropium Respimat® improved lung function in children with asthma aged 6-17 and is well-tolerated compared to placebo in children aged 1-171-5

  • New CanoTinA-asthma® trial results showed adding tiotropium Respimat® improved lung function in children aged 6-111,2
  • Additional pooled data support the efficacy and safety of tiotropium Respimat® in children aged 6-173,4
  • Safety profile of tiotropium Respimat® in children aged 1-5 years is consistent with that in older...

    Continue Reading

06 Sep 2016

Tailgating is a growing concern, but overall UAE driving perceptions improve – UAE Road Safety Monitor

  • RoadSafetyUAE and QIC Insured present the findings of the 3rd cycle of the ‘UAE Road Safety Monitor’, a unique perception study of UAE driving behaviour.
  • Tailgating is on the rise.
  • Positive perception trends of improved infrastructure, commute time and driving enjoyment.
  • Perception...

    Continue Reading
Found articles: 50 - Pages  « 3 4 5 
Contact US | Powered by CNPHUB.com - All Rights Reserved